A Phase 1 Randomised, Double Blind, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Intra-articular Progenza (PRG) in Adults with Symptomatic Knee Osteoarthritis
Phase of Trial: Phase I
Latest Information Update: 11 Jul 2017
At a glance
- Drugs Adipose-derived allogeneic stem cell therapy-Regeneus (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Acronyms STEP
- Sponsors Regeneus ltd
- 08 Jul 2017 Status changed from active, no longer recruiting to completed.
- 04 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 13 Jun 2015 New trial record